Synbio Tech Inc. (TPEX:1295)
Taiwan · Delayed Price · Currency is TWD 45.20
-1.00 (-2.16%)
Oct 30, 2026, 1:30 PM CST
Synbio Tech Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,558 | 2,930 | 2,352 | 2,475 | - | - | |
Market Cap Growth | -58.34% | 24.61% | -4.97% | - | - | - |
Enterprise Value | 2,701 | 3,922 | 2,807 | 2,979 | - | - |
Last Close Price | 45.20 | 81.06 | 68.19 | 70.15 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.00 | 16.65 | 13.82 | 21.85 | - | - |
Forward PE | - | 11.54 | - | - | - | - |
PS Ratio | 1.55 | 2.82 | 2.38 | 3.01 | - | - |
PB Ratio | 1.19 | 2.20 | 2.18 | 2.62 | - | - |
P/TBV Ratio | 1.21 | 2.24 | 2.23 | 2.68 | - | - |
P/OCF Ratio | 8.49 | 20.44 | 8.99 | 11.57 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.68 | 3.78 | 2.84 | 3.62 | - | - |
EV/EBITDA Ratio | 11.08 | 14.49 | 10.10 | 13.85 | - | - |
EV/EBIT Ratio | 20.74 | 19.78 | 13.41 | 20.84 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.25 | 1.04 | 0.88 | 0.78 | 0.70 | 0.59 |
Debt / EBITDA Ratio | 6.74 | 5.06 | 3.38 | 3.33 | 3.52 | 1.98 |
Debt / FCF Ratio | - | - | - | - | - | 2.27 |
Net Debt / Equity Ratio | 0.87 | 0.84 | 0.45 | 0.41 | 0.45 | 0.37 |
Net Debt / EBITDA Ratio | 4.76 | 4.13 | 1.74 | 1.79 | 2.32 | 1.28 |
Net Debt / FCF Ratio | -3.93 | -1.99 | -11.93 | -3.40 | -13.63 | 1.44 |
Asset Turnover | 0.34 | 0.38 | 0.47 | 0.46 | 0.46 | 0.59 |
Inventory Turnover | 2.02 | 2.34 | 2.84 | 2.66 | 2.43 | 2.84 |
Quick Ratio | 0.76 | 0.63 | 1.42 | 2.31 | 1.41 | 0.84 |
Current Ratio | 1.09 | 1.20 | 1.86 | 3.10 | 3.00 | 1.90 |
Return on Equity (ROE) | 11.21% | 14.61% | 16.82% | 12.31% | 10.51% | 19.73% |
Return on Assets (ROA) | 2.72% | 4.56% | 6.19% | 5.01% | 3.95% | 7.99% |
Return on Invested Capital (ROIC) | 5.11% | 8.60% | 10.41% | 8.38% | 6.53% | 13.46% |
Return on Capital Employed (ROCE) | 5.40% | 8.10% | 10.80% | 8.50% | 7.00% | 15.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.09% | 6.00% | 7.23% | 4.58% | - | - |
FCF Yield | -18.67% | -19.10% | -1.73% | -4.58% | - | - |
Dividend Yield | 6.64% | 3.53% | 4.67% | 1.86% | - | - |
Payout Ratio | 72.80% | 62.37% | 27.10% | 54.28% | 75.82% | 37.77% |
Buyback Yield / Dilution | -8.72% | -5.85% | -0.01% | -0.02% | -0.98% | -0.63% |
Total Shareholder Return | -2.08% | -2.32% | 4.66% | 1.84% | -0.98% | -0.63% |